Anbio Biotechnology

NNNN
$7.59 (- $1.15 - 13.16%)
Last updated: 2026-08-17 15:25 UTC
NNNN Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINKYG0367B1059
Market Price7.59
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio716.8
EPS0.05
Market Cap$1.6B
Book Value0.41
Price to Book88.059
BetaN/A
52w High55.65
52w Low5.18
Next Earnings DateN/A

Anbio Biotechnology trades under ticker NNNN on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN KYG0367B1059.

Related researchNNNN stock priceNNNN share priceAnbio Biotechnology stockAnbio Biotechnology share price
About the Company
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Price History